Breaking News

Merck KGaA, Maker of Erbitux Cancer Drug, to Acquire Sigma-Aldrich for $17 Billion
Tweet TWEET

Barry Ritholtz

10 Morning Reads: Taming the Hedge-Fund Beast

My morning reads, fresh from northern Connecticut:

• 3 Reasons Stocks Could Move Significantly Higher (Ciavacco Capital) but see 3 signs the market is primed for a fall (MSN)

• Investors need to starve the hedge fund beast (FT)

• Not a lot of Fresh Ideas on Wall Street (DealBook) except for criminalsMarkets Evolve, as Does Financial Fraud (DealBook)

• Could Iran Be on Investors’ Radar? (Businessweek)

• It looks like the economy might actually recover in 2014. But will it? (Washington Post)

• Here’s Why That Story About The Fed Guy Apologizing For QE Is Total Nonsense (Business Insider) see also For Yellen, Fed’s Dual Mandate Guides Thinking (WSJ)

• Netflix’s New Look Is a Glimpse at the Future of TV (Wired)

• Reinventing The Dwindling Middle Class May Take A Revolution (NPR) see also Switzerland’s Proposal to Pay People for Being Alive (NY Times)

• Profits? Amazon Prefers Technology (MIT Technology Review)

• Hydropower is back. The largest source of renewable energy is surging with mega dams, dam conversions, upgrades and new ideas. (WSJ)

What are you reading?

The Future of Energy

Source: WSJ

Source: WSJ

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.